	Despesas De Vendas E Administração		Data
AbbVie	USD 3.89B	325M	2025-12
Amgen	USD 1.94B	237M	2025-12
Anika Therapeutics	USD 12.91M	17.8M	2025-03
Arrowhead Research	USD 46.02M	8.84M	2025-12
AstraZeneca	USD 4.61B	4.46B	2025-12
BioCryst Pharmaceuticals	USD 80.47M	15.39M	2024-12
Biogen	USD 545.2M	38.6M	2025-09
Bristol-Myers Squibb	USD 2.18B	392M	2025-12
Enanta Pharmaceuticals	USD -1.05	0.31	2024-12
Gilead Sciences	USD 1.78B	425M	2025-12
GlaxoSmithKline	GBP 2.68B	518M	2025-12
Halozyme Therapeutics	USD 64.64M	27.11M	2025-12
Heron Therapeutics	USD 23.34M	4.18M	2024-09
Immunic	USD -0.24	0.03	2024-09
Incyte	USD 390.41M	61.33M	2025-12
Insmed	USD 212.48M	26.11M	2025-12
Ionis Pharmaceuticals	USD 130M	43.43M	2025-12
J&J	USD 6.75B	831M	2025-12
Karyopharm Therapeutics	USD 27.19M	442K	2024-12
Ligand Pharmaceuticals	USD 28.45M	8.27M	2025-09
Merck	USD 2.85B	215M	2025-12
Neurocrine Biosciences	USD 301.8M	10.2M	2025-12
Novartis	USD 3.31B	134M	2025-09
Novavax	USD 66.95M	34.05M	2024-09
Pfizer	USD 4.08B	894M	2025-12
PTC Therapeutics	USD 87.2M	3.15M	2025-12
Roche Holding	CHF 7.28B	3.99B	2025-12
Sarepta Therapeutics	USD 105.38M	28.27M	2025-12
Vertex Pharmaceuticals	USD 487M	41.9M	2025-12

Enanta Pharmaceuticals Despesas De Vendas E Administração - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Mar 2026.